Transfusion and Apheresis Science
Volume 30, Issue 1 , Pages 29-39 , February 2004

Nitric oxide infusion alleviates cellular activation during preparation, leukofiltration and storage of platelets

  • Kenneth Wong

      Affiliations

    • Canadian Blood Services, Calgary Centre, 737-13 Ave. S.W., Calgary, Canada AB T2R 1J1
    • Department of Pharmacology and Therapeutics, University of Calgary, Calgary, Alberta, Canada T2N 4N1
    • Corresponding Author InformationCorresponding author. Address: Canadian Blood Services, 737-13 Ave. S.W., Calgary, Canada AB T2R 1J1. Tel.: +1-403-410-2674/2676; fax: +1-403-410-2794
    • ,
  • Xuebin Li

      Affiliations

    • Canadian Blood Services, Calgary Centre, 737-13 Ave. S.W., Calgary, Canada AB T2R 1J1

Received 1 May 2003 ,Revised 1 July 2003 ,Accepted 1 July 2003.

References 

  1. Klinger MH. The storage lesion of platelets: ultrastructural and functional aspects. Ann. Hematol. 1996;73:103–112
  2. Seghatchian J, Krailadsiri P. The platelet storage lesion. Transfus. Med. Rev. 1997;11:130–144
  3. Bode AP, Holme S, Heaton WA, Swanson MS. Sustained elevation of intracellular cyclic 3′-5′ adenosine monophosphate is necessary for preservation of platelet integrity during long-term storage at 22 °C. Blood. 1994;83:1235–1243
  4. Mrowiec ZR, Oleksowicz L, Zuckerman D, De Leon-Fernandez M, Khorshidi M, Dutcher JP, et al.  Buffy coat platelets stored in apyrase, aprotinin, and ascorbic acid in a suspended bag: combined strategies for reducing platelet activation during storage. Transfusion. 1996;36:5–10
  5. Rivera J, Lozano ML, Corral J, Connor J, Gonzalez-Conejero R, Ferrer F, et al.  Quality assessment of platelet concentrates supplemented with second-messenger effectors. Transfusion. 1999;39:135–143
  6. Wood EM, Colton E, Yomtovian RA, Currie LM, Connor J, Anderson JM. Prevention of monocyte adhesion and inflammatory cytokine production during blood platelet storage: an in vitro model with implications for transfusion practice. J. Biomed. Mater. Res. 2000;51(2):147–154
  7. Radomski MW, Palmer RMJ, Moncada S. An l-arginine nitric oxide pathway present in human platelets regulates aggregation. Proc. Natl. Acad. Sci. USA. 1990;87:5193–5197
  8. Radomski MW, Moncada S. The biological and pharmacological role of nitric oxide in platelet function. Adv. Exp. Med. Biol. 1993;344:251–264
  9. Radomski MW, Zakar T, Salas E. Nitric oxide in platelets. Meth. Enzymol. 1996;269:88–107
  10. Riddell DR, Owen JS. Nitric oxide and platelet aggregation. Vitam. Horm. 1999;57:25–48
  11. Buechler WA, Ivanova K, Wolfram G, Drummer C, Heim JM, Gerzer R. Soluble guanylyl cyclase and platelet function. Ann. NY Acad. Sci. 1994;714:151–157
  12. Moro MA, Russel RJ, Cellek S, Lizasoain I, Su Y, Darley-Usmar VM, et al.  cGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase. Proc. Natl. Acad. Sci. USA. 1996;93:1480–1485
  13. McFarlane DE, Mills DC. Inhibition by ADP of prostaglandin induced accumulation of cyclic AMP in intact human platelets. J. Cycl. Nucl. 1981;7:1–11
  14. Tsikas D, Ikic M, Tewes KS, Raida M, Frolich JC. Inhibition of platelet aggregation by S-nitroso-cysteine via cGMP-independent mechanisms: evidence of inhibition of thromboxane A2 synthesis in human blood platelets. FEBS Lett. 1999;442:162–166
  15. Haslam R, Dickinson N, Jang EK. Cyclic nucleotides and phosphodiesterases in platelets. Thromb. Haemost. 1999;82:412–423
  16. Yan B, Smith JW. A redox site involved in integrin activation. J. Biol. Chem. 2000;275:39964–39972
  17. Pedigo M, Wun T, Paglieroni T. Removal by white cell-reduction filters of activated platelets expressing CD62. Transfusion. 1993;339:30–35
  18. Geiger TL, Perrotta PL, Davenport R, Baril L, Snyder EL. Removal of anaphylatoxins C3a and C5a and chemokines interlukin 8 and RANTES by polyester white cell-reduction and plasma filters. Transfusion. 1997;37:1156–1162
  19. Krailadsiri P, Seghatchian J. Negatively charged leukocyte filter significantly enhances kallikrein and thrombin-like activities of platelet concentrates. Thromb. Res. 1996;83:469–474
  20. Devine DV, Bradley AJ, Maurer E, Levin E, Chahal S, Serrano K, et al.  Effects of prestorage white cell reduction on platelet aggregate formation and the activation state of platelets and plasma enzyme systems. Transfusion. 1999;39:724–734
  21. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and the ugly. Am. Physiol. Soc. 1996;271:C1424–C1437
  22. O’Neill S, Dutta S, Triggle C. Computerized acquisition and analysis applied to chemiluminescence detection of nitric oxide in headspace gas. J. Pharmacol. Toxicol. Meth. 1993;29:217–221
  23. Trottier G, Triggle C, O’Neill SK, Loutzenhiser R. Cyclic GMP-dependent and cyclic GMP-independent actions of nitric oxide on the renal afferent arteriole. Br. J. Pharmacol. 1998;125:563–569
  24. Park J, Kostka P. Fluorometric detection of biological S-nitrosothiols. Anal. Biochem. 1997;249:61–66
  25. Stamler JS, Jaraki O, Osborne J, Simon DI, Keaney J, Vita J, et al.  Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proc. Natl. Acad. Sci. USA. 1992;89:7674–7677
  26. Butler AR, Rhodes P. Chemistry, analysis, and biological roles of S-nitrosothiols. Anal. Biochem. 1997;249:1–9
  27. Kelm M. Nitric oxide metabolism and breakdown. Biochim. Biophys. Acta. 1999;1411:273–289
  28. Marley R, Feelisch M, Holt S, Moore K. A chemiluminescense-based assay for S-nitrosoalbumin and other plasma S-nitrosothiols. Free Radic. Res. 2000;32:1–9
  29. Kostelijk EH, Fijnheer R, Nieuwenhuis HK, Gouwerok CW, de Korte D. Soluble P-selectin as parameter for platelet activation during storage. Thromb. Haemost. 1996;76:1086–1089
  30. Bode AP, Miller DT, Newman SL, Castellani WJ, Norris HT. Plasmin activity and complement activation during storage of citrated platelet concentrates. J. Lab. Clin. Med. 1989;113:94–102
  31. Miletic VD, Popovic O. Complement activation in stored platelet concentrates. Transfusion. 1993;33:150–154
  32. Gyongyossy-lssa MIC, McLeod E, Devine DV. Complement activation in platelet concentrates is surface-dependent and modulated by the platelets. J. Lab. Clin. Med. 1994;123:859–868
  33. Radomski MW, Palmer RM, Read NG, Moncada S. Isolation and washing of human platelets with nitric oxide. Thromb. Res. 1988;50:537–546
  34. Lozano M, Estebanell E, Cid J, Diaz-Ricart M, Mazzara R, Ordinas A, et al.  Platelet concentrates prepared and stored under currently optimal conditions: minor impact on platelet adhesive and cohesive functions after storage. Transfusion. 1999;39:951–959
  35. Kroll MH, Hellums JD, McIntire LV, Schafer AI, Moake JL. Platelet and shear stress. Blood. 1996;88:1525–1541
  36. Polascik T, Godfrey PP, Watson SP. Neomycin cannot be used as a selective inhibitor of inositol phospholipid hydrolysis in intact or semi-permeabilized human platelets. Aminoglycosides activate semi-permeabilized platelets. Biochem. J. 1987;243:815–819
  37. Keaney JF, Simon DI, Stamler JS, Jaraki O, Scharfstein J, Vita JA, et al.  NO forms an adduct with serum albumin that has endothelium-derived relaxing factor-like properties. J. Clin. Invest. 1993;91:1582–1589
  38. Kelm M, Schrader J. Control of coronary vascular tone by nitric oxide. Circ. Res. 1990;66:1561–1575
  39. Trepakova ES, Cohen RA, Bolotina VM. Nitric oxide inhibits capacitative cation influx in human platelets by promoting sarcoplasmic/endoplasmic reticulum Ca2+-ATPase-dependent refilling of Ca2+ stores. Circ. Res. 1999;84:201–209
  40. Wang GR, Zhu Y, Halushka PV, Lincoln TM, Mendelsohn ME. Mechanism of platelet inhibition by nitric oxide: in vivo phosphorylation of thromboxane receptor by cyclic GMP-dependent protein kinase. Proc. Natl. Acad. Sci. USA. 1998;95:4888–4893
  41. Pigazzi A, Heydrick S, Folli F, Benoit S, Michelson A, Loscalzo J. Nitric oxide inhibits thrombin receptor-activating peptide-induced phosphoinositide 3-kinase activity in human platelets. J. Biol. Chem. 1999;274:14368–14375
  42. Brune B, Hanstein K. Rapid reversibility of nitric oxide induced platelet inhibition. Thromb. Res. 1998;90:83–91

PII: S1473-0502(03)00197-6

doi: 10.1016/j.transci.2003.07.001

Transfusion and Apheresis Science
Volume 30, Issue 1 , Pages 29-39 , February 2004

Article Tools

* Image Usage & Resolution